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Embryonic origin of human hematopoiesis
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ABSTRACT  Hematopoietic stem cells (HSC) are at the origin of the adult hematopoietic system.
They give rise to all blood cells through a complex series of proliferation and differentiation events
that occur throughout the lifespan of the individual. Because of their potential clinical importance
in transplantation, recent research has focused on the developmental origins of embryonic HSC.
During development in vertebrate embryos, two independent anatomical sites generate hemato-
poietic cells. The yolk sac is responsible for a first ephemeral hematopoiesis, characterized by the
early appearance of hematopoietic progenitors with limited development ability that rapidly
differentiate toward erythro-myeloid lineages. Self-renewing, multipotent adult-type HSC that
also exhibit B and T lymphoid potentials emerge autonomously in the aorta/gonad/mesonephros
(AGM) region inside the embryo. In this review, we provide a brief summary of recent develop-
ments regarding the origins of hematopoietic stem cells in the early human embryo. The recent
discovery that angiotensin-converting enzyme (ACE) is a novel cell surface marker of human HSC
is discussed in detail.
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Introduction
The hematopoietic system consists in a large array of differen-
tiated blood cells including erythocytes and cells of the myeloid
and lymphoid lineages. These mature blood cells have a limited
lifespan and are continuously replaced by the proliferation and
differentiation of a very small cohort of pluripotent hematopoietic
stem cells (HSC). Indeed, HSC have the ability to replenish their
own compartment (i.e., they demonstrate self renewal) and to
differentiate into progenitor cells and mature blood cells of all
hematopoietic lineages. In adult mammals, blood cells are gener-
ated primarily within the medullary cavity of some bones. It is
generally considered that HSC encountered in the adult bone
marrow arise by replication and amplification of a stock of HSC
that emerged early in ontogenesis, when the bone marrow had
not yet formed.
As in all other vertebrates, human hematopoiesis begins in the
yolk sac (YS) and then takes place transitorily in the liver, before
being definitively established in the thymus and bone marrow.
Studies performed in other species, namely mouse and chicken,
have indicated that all hematopoietic organs (liver, thymus and
also the bone marrow) do not produce their own hematopoietic
precursors but have to be colonized by extrinsic blood progenitor
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cells (Le Douarin et al., 1984; Moore and Owen, 1967). This
pathway set the basis for the prevailing idea that the YS was the
only site of de novo blood-cell generation from HSC (Moore and
Metcalf, 1970). In contrast, experiments in birds later demon-
strated that definitive hematopoiesis stems from precursors emerg-
ing in the embryo proper, localized in a region neighboring the
dorsal aorta (reviewed in Dieterlen-Lievre, 1994). In mammals,
evidence for an intraembryonic emergence of hematopoietic
progenitors was obtained in mice and in the human embryo. In the
mouse, the aorta-gonad-mesonephros (AGM) region, a territory
homologous to that identified in birds, and its anlage, the paraaortic
splanchnopleura (P-Sp), are endowed with hematopoietic poten-
tial (reviewed in Dzierzak and Speck, 2008). Indeed, cells ex-
pressing markers of hematopoietic progenitors are present in the
dorsal aorta (reviewed in Cumano and Godin, 2007). We have
participated in this discovery by identifying in the human embryo
a dense population of HSC emerging in association with the
ventral side of the aortic endothelium, between the 27th and the
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40th day of development (reviewed in Tavian and Peault, 2005a).
In the following review we will present an overview of advances
in the field of human developmental hematopoiesis. In the first
part, we show evidence for the independent generation of intra-
embryonic hematopoietic precursors. Second, through the analy-
sis of the expression of ACE, a novel marker of HSC, we point to
the very origin of human embryonic hematopoiesis.
The embryo proper as a site of blood cell generation
The first evidence for the existence of an intrinsic blood cell
activity inside the human embryo was reported by the group of L.
Coulombel using colony assays established with CD34+ cells
purified from extraembryonic yolk sacs and intraembryonic tis-
sues (Huyhn et al., 1995). Under these conditions non-erythroid
progenitors were predominantly found in the embryo, whereas
erythroid progenitors were more equally distributed. In particular,
a higher proportion of non-erythroid progenitors (including high-
proliferative potential cells, HPP-CFC) was present among cells
remaining after the liver has been removed, indicating that
intraembryonic hematopoietic activity was not predominantly
hepatic (Huyhn et al., 1995).
The presence inside the embryonic compartment of progeni-
tors presenting a HSC phenotype was corroborated by our group
which identified a dense population of CD34+ blood cells adhering
to the ventral side of the aortic endothelium (Fig. 1A) (Tavian et al.,
1996). This cell population displayed a cell-surface and molecular
phenotype typifying primitive hematopoietic progenitors (CD45+,
CD34+, CD31+, CD38-, negative for lineage markers, GATA-2+,
GATA-3+, c-myb+, SCL/TAL1+, c-kit+, flk-1/KDR+) (Labastie et al.,
1998; Tavian et al., 1996). Hematopoietic cell clusters appeared
precisely in the embryo between the 27th and 40th days of
development, which corresponded to 2–3 days before hepatic
in vitro assay (for experimental details, see Tavian and Peault,
2005c). Under these conditions we have assayed each compart-
ment before and after the 21-day stage, which marks the onset of
blood circulation. Successively the splanchnopleura (the pre-
sumptive dorsal aorta), the paraaortic splanchnopleura, and the
aorta itself were dissected out and cultured. Matching YSs were
analyzed under the same conditions in all experiments. From 27
to 40 days of gestation, when intravascular HSC clusters were
present, the aorta expectedly established long-term hematopoi-
etic cell cultures. The same potential, however, was already
observed within the 19-day splanchnopleura (i.e., 3 days before
the onset of blood circulation and 1 week before the detection of
recognizable HSC clusters in the aorta). In conclusion, hemato-
poietic progenitors emerge autonomously in the YS but also
within the human embryo proper, from the splanchnopleural
mesoderm (Tavian et al., 2001).
The embryo but not the yolk sac generates multipotent
lymphomyeloid stem cells
Cells derived from these two independent blood stem cell
generation sites, the intraembryonic splanchnopleura and YS,
were cultured on the MS-5 murine stroma cell line, which permits
the long-term development of both myeloid and lymphoid human
progenitors. In these settings, we showed that the yolk sac only
generates progenitor cells with limited development ability,
whereas progenitors emerging autonomously in the presumptive
aortic territory are endowed with multilineage lympho-myeloid
potential (Tavian et al., 2001). Therefore, the first and only
multipotent, myelolymphoid stem cells are generated in the
splanchnopleura, within the embryo proper, and are physically
present within trunk arteries during the fifth week of development.
These cells were therefore suggested to be at the origin of
definitive hematopoiesis (Tavian et al., 2001).
Fig. 1. Hematopoietic stem cell clusters inside human embryonic arteries. (A) Cross
sections of a 34-day human aorta (Ao) stained with the anti-CD34 (green) and anti-CD45 (red)
antibodies. Arrows indicate the clusters of hematopoietic stem cells adhering to the ventral
aspect of the aortic endothelium (white arrowhead). (B) Confocal images at higher magnifi-
cation of the region included in the dotted white line in panel A show the changed morphology
of endothelial cells underlying hematopoietic clustered progenitors (arrow).
B
A
colonization by CD34+ progenitors (Tavian et al.,
1999). Therefore, thousands of hematopoietic
cells were clustered on the endothelium of the
dorsal aorta and vitelline artery indicating the
existence in this organ of a localized microenvi-
ronment which could regulate cell fate, both
spatially and temporally. A number of circum-
stantial observations have been already made in
this respect such as the presence of an accumu-
lation of smooth actin-positive cells and the high
expression of tenascin-C, indicating local
changes in the mesoderm underneath the clus-
ters (Marshall et al., 1999; also reviewed in
Tavian and Peault, 2005b).
The embryo is hemogenic even before the
aorta forms
The possibility that these cells were derived
from YS blood islands, rather than generated
locally within the embryo proper, has been ruled
out by investigations performed at earlier devel-
opmental stages, when blood does not yet circu-
late between the YS and the embryo.
The developmental potential of human em-
bryonic and YS-derived cells, in terms of blood
cell lineages, was analyzed in a novel multistep
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Intraembryonic hematopoiesis: what is the origin of
HSC?
Despite the progress made in the last decade in the under-
standing of hematopoietic stem cell development during embryo-
genesis, the cellular identity of the population responsible for this
early activity still remains unknown. Several hypotheses have
been proposed.
Hemangioblasts or «hemogenic» endothelial cells?
Since in the primitive sites of blood cell emergence – the yolk
sac and the aorta – HSC stem in close physical association with
endothelial cells, the current models for hematopoietic cell gen-
eration emphasize a direct ontogenic link between the two lin-
eages.
In the yolk sac, the blood islands are generated by mesodermal
cell aggregates, which differentiate into both hematopoietic and
endothelial cells. The simultaneous appearance of these two
lineages suggested the existence of a common ancestral precur-
sor for endothelial and hematopoietic cells – the hemangioblast
(Murray, 1932). Further and more recent supporting evidence for
a lineage relationship includes the observation that the two cell
types share a number of surface markers and that null mutations
in a number of genes, such as flk1 (Shalaby et al., 1997), affect
both cell lineages. In contrast to the yolk sac, hematopoietic
activity inside the embryo occurs when endothelial cells are
already present, which makes it difficult to link the emergence of
intraembryonic blood cells to a population of hemangioblasts.
These observations set the basis for the idea that endothelial cells
themselves could play a major role in blood cell development. The
existence of a «hemogenic» endothelium which can give rise to
hematopoietic cells, first suggested in 1920 by Sabin (Sabin,
1920), has been recently demonstrated for avian and mouse
intraembryonic hematopoiesis (de Bruijn et al., 2002; Jaffredo et
al., 1998; Nishikawa et al., 1998; Pouget et al., 2006). In agree-
ment with these reports, we have observed that, also in the human
embryo, endothelial cells located on the ventral site of the dorsal
aorta present a morphology distinct from those the endothelium of
the dorsal site. On the ventral aspect site, the normal layer of
endothelial cells lining the lumen of the aorta is disrupted and
replaced by a less organized population of rounded cells (Fig. 1B).
Prompted by these observations, we sorted by flow cytometry
vascular endothelial cells from embryonic and fetal human blood-
forming tissues and analyzed their hematopoietic ability by cul-
Fig. 2. Expression of BB9/angiotensin-converting-enzyme (BB9/ACE) in the human embryo.
Cross sections through the dorsal aorta (Ao) in a 34-day embryo. BB9/ACE is expressed by
hematopoetic CD34+CD45+ cell clusters associated with the endothelium on the ventral site of the
aorta (arrowheads), as well as by underlying endothelial CD34+ cells (white arrowheads).
Alternative models: mesodermal precursors?
The experiments described above suggested that ventral
endothelial cells in human intraembryonic arteries divide and
differentiate into blood cell progenitors at the origin of definitive
hematopoiesis (Oberlin et al., 2002). However, endothelial
CD34+CD45- cells sorted from the human splanchnopleura as
late as days 24-26 of gestation - when a hemogenic ability exists
in vitro but the aortic HSC clusters are not yet present – yielded
no blood cell progeny in culture. Conversely, the blood-forming
potential in these early embryos was entirely confined within the
CD34-CD45- cell subset (MT, personal observations). This posits
the presence in the splanchnopleural mesoderm of CD34- precur-
sors possibly committed toward a hematopoietic fate, which
would migrate through the peri-aortic mesenchyme and be at the
origin of the HSC associated with the vascular endothelium from
day 27 of development (Tavian and Peault, 2005c).
An alternative to the hemogenic endothelium has also been
suggested in the mouse embryo, based on the presence of
structures potentially involved in intraembryonic HSC generation
- the subaortic patches, SAPs -, located below the aortic floor
(Bertrand et al., 2005; Manaia et al., 2000). The phenotype of the
cells included in SAPs suggests that the hemogenic ability is
restricted to precursors with a non-endothelial antigen expression
profile (Bertrand et al., 2005; Manaia et al., 2000). According to
this model, HSC would be generated within SAPs, migrate toward
the aortic floor and reach the blood flow to colonize the fetal liver.
This transition across the ventral endothelium of the aorta could
justify the presence of a hemogenic endothelium which is de-
tected only at certain stages of development when the HSC are
present in the AGM (Oberlin et al., 2002; also reviewed in Cumano
and Godin, 2007).
BB9/ACE (angiotensin-converting enzyme), a novel
marker of HSC, can identify pre-hematopoietic precur-
sors inside the human embryo
BB9 is a monoclonal antibody (mAb) initially described to react
in adult human bone marrow with stromal cells and with a
subpopulation of CD34+ cells presenting the phenotypic charac-
teristics of immature progenitors, namely low to undetectable
levels of CD38 and coexpression of CD90 and CD133 (Ramshaw
et al., 2001).
In a recent study we have shown that BB9, which turned out to
recognize the somatic isoform of the angiotensin converting
ture over a layer of MS-5 stromal cells. In
this context, endothelial cells sorted from
the human embryonic aorta between 27
and 40 days of development – when HSC
are present in this region – gave rise to
vigorous hematopoiesis. The frequency of
hematogenous endothelial cells in the AGM,
at a given stage of human ontogeny, was
directly correlated with the hematopoietic
activity of this territory. Conversely, no he-
matopoietic activity was detected in cul-
tured endothelial cells sorted from the AGM
region after day 40, when HSC are no
longer present in the lumen of the aorta
(Oberlin et al., 2002).
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enzyme (ACE/CD143), exhibits reactivity with primitive hemato-
poietic cells at all stages of hematopoietic ontogeny including in
the umbilical cord blood (UCB) and fetal liver. Transplantations
into NOD/SCID mice demonstrated that CD34+BB9+ cells from
UCB, but not CD34+ cells lacking expression of BB9, sustained
multilineage human hematopoietic cell engraftment and, there-
fore, clearly established BB9/ACE as a bona fide marker of
human HSC (Jokubaitis et al., 2008).
In the attempt to track the earliest forerunners of intraembryonic
blood forming activity, we have recently examined BB9 expres-
sion in earlier human embryos. We observed that ACE also
identifies hematopoietic clusters (Fig. 2) emerging on the ventral
aortic endothelium at 4-5-weeks, as well as the neighboring
endothelial cells (Jokubaitis et al., 2008). In addition, BB9 identi-
fied a few cells scattered among the subaortic mesoderm, on
which no colocalization of CD34 or CD45 was observed, suggest-
ing the angiohematopoietic potential of BB9-positive mesodermal
progenitors (Jokubaitis et al., 2008). An analysis conducted at
even earlier stages of human development is consistent with this
hypothesis (Sinka et al., submitted). Indeed, starting from day 19
until 26 days of gestation, when HSC clusters are not yet devel-
oped within the vascular aortic wall, BB9/ACE expression marks
rare CD34-CD45- cells in the embryo proper, scattered in the
hemogenic portion of the P-Sp. Along these lines, results ob-
tained by culturing cells sorted from 24- to 26-day human embryos
indicate that BB9+, but not BB9 cells, are endowed with hemato-
poietic ability (Sinka et al. submitted). In accord with these
observations, a recent study of human embryonic stem cells
(hESC) has shown that hESC derived ACE+CD45-CD34+/- cells
are common yolk sac-like progenitors for not only endothelium,
but also both primitive and definitive human lympho-hematopoi-
etic stem cells (Zambidis et al., 2008).
Conclusions
Altogether, these findings put forth the concept that BB9/ACE,
already accepted as a novel marker for very primitive HSC, could
also mark pre-hematopoietic cells inside the human mesoderm,
which would imply that definitive hematopoiesis arises inside the
human embryo from intrinsic mesodermal stem cells identifiable
with the BB9 antibody, and thereby expressing ACE.
This pattern supports the hypothesis of the existence of a
BB9+CD34-CD45- hemangioblastic precursor cell that migrates
from the P-Sp toward the ventral aorta, to give rise to
BB9+CD34+CD45+ hematopoietic progenitors and underlying
BB9+CD34+CD45- endothelial cells. In accord with such an inter-
pretation, a recent work has shown, through lineage tracing
approaches, that the endothelium lining the ventral wall of the
aorta is responsible for HSC emergence in the mouse AGM and
that this hemogenic endothelium is derived from a transient
mesenchymal population (Zovein et al., 2008).
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